These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8218537)

  • 1. Effect of recombinant human erythropoietin after allogenic bone marrow transplantation.
    Link H; Brune T; Hübner G; Diedrich H; Freund M; Stoll M; Peest D; Ebell W; Bettoni C; Oster W
    Ann Hematol; 1993 Oct; 67(4):169-73. PubMed ID: 8218537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of recombinant human erythropoietin after bone marrow transplantation.
    Link H; Boogaerts MA; Fauser AA; Slavin S; Reiffers J; Gorin NC; Carella AM; Mandelli F; Burdach S; Ferrant A
    Blood; 1994 Nov; 84(10):3327-35. PubMed ID: 7949088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomised double-blind trial of the in vivo use of recombinant human erythropoietin in bone marrow transplantation from HLA-identical sibling donors. The Australian Bone Marrow Transplant Study Group.
    Biggs JC; Atkinson KA; Booker V; Concannon A; Dart GW; Dodds A; Downs K; Szer J; Turner J; Worthington R
    Bone Marrow Transplant; 1995 Jan; 15(1):129-34. PubMed ID: 7742745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
    Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
    Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants.
    Locatelli F; Zecca M; Pedrazzoli P; Prete L; Quaglini S; Comoli P; De Stefano P; Beguin Y; Robustelli della Cuna G; Severi F
    Bone Marrow Transplant; 1994 Apr; 13(4):403-10. PubMed ID: 8019464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants.
    Beguin Y; Oris R; Fillet G
    Bone Marrow Transplant; 1993 Apr; 11(4):285-92. PubMed ID: 8485476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients.
    van Iperen CE; Gaillard CA; Kraaijenhagen RJ; Braam BG; Marx JJ; van de Wiel A
    Crit Care Med; 2000 Aug; 28(8):2773-8. PubMed ID: 10966249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants.
    Beguin Y; Clemons GK; Oris R; Fillet G
    Blood; 1991 Feb; 77(4):868-73. PubMed ID: 1847085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
    Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
    Bone Marrow Transplant; 1994 Apr; 13(4):397-402. PubMed ID: 8019463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
    Vannucchi AM; Bosi A; Ieri A; Guidi S; Saccardi R; Lombardini L; Linari S; Laszlo D; Longo G; Rossi-Ferrini P
    Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation.
    Fujimori Y; Kanamaru A; Saheki K; Mori A; Takatsuka H; Wada H; Okada M; Tamura S; Okamoto T; Takemoto Y; Kakishita E; Nagai K
    Int J Hematol; 1998 Feb; 67(2):131-6. PubMed ID: 9631579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs.
    Mitus AJ; Antin JH; Rutherford CJ; McGarigle CJ; Goldberg MA
    Blood; 1994 Apr; 83(7):1952-7. PubMed ID: 8142661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin treatment in allogeneic BMT accelerates erythroid reconstitution: results of a prospective controlled randomized trial.
    Steegmann JL; López J; Otero MJ; Lamana ML; de la Cámara R; Berberana M; Díaz A; Fernández-Rañada JM
    Bone Marrow Transplant; 1992 Dec; 10(6):541-6. PubMed ID: 1490203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation.
    Locatelli F; Zecca M; Beguin Y; Giorgiani G; Ponchio L; De Stefano P; Cazzola M
    Br J Haematol; 1993 Aug; 84(4):752-4. PubMed ID: 8217839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum erythropoietin levels and blood component therapy after autologous bone marrow transplantation: implications for erythropoietin therapy in this setting.
    Lazarus HM; Goodnough LT; Goldwasser E; Long G; Arnold JL; Strohl KP
    Bone Marrow Transplant; 1992 Jul; 10(1):71-5. PubMed ID: 1515882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing autologous blood donation by recombinant human erythropoietin (rhu-EPO) and interleukin 3 (IL-3).
    Krieter H; Frey L; Segiet W; Brückner UB; Krumwieh D; Seiler FR; Messmer K
    Behring Inst Mitt; 1991 Dec; (90):75-85. PubMed ID: 1801694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maze learning impairment is associated with stress hemopoiesis induced by chronic treatment of aged rats with human recombinant erythropoietin.
    Rifkind JM; Abugo OO; Peddada RR; Patel N; Speer D; Balagopalakrishna C; Danon D; Ingram DK; Spangler EL
    Life Sci; 1999; 64(4):237-47. PubMed ID: 10027758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of recombinant human erythropoietin on perioperative transfusion requirements in patients having a major orthopaedic operation. The American Erythropoietin Study Group.
    Faris PM; Ritter MA; Abels RI
    J Bone Joint Surg Am; 1996 Jan; 78(1):62-72. PubMed ID: 8550681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
    Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
    Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.